Loading organizations...
Pureland Global Venture is a direct investment fund focused on impact opportunities within the medical technology sector. A global healthcare venture firm, it invests in companies developing innovative software and hardware solutions. These aim to advance disease prevention, refine treatment, and enhance medical efficiency, improving healthcare delivery.
Pureland Group, a private investment entity, began in Singapore in 2014, laying Pureland Global Venture's foundation. The venture capital arm was created from the insight that focused capital accelerates transformative healthcare innovations. Its inception reflects dedication to addressing critical needs within the evolving medical landscape.
Pureland Global Venture partners with medical technology companies delivering novel solutions for patient care and operational improvements. Its mission facilitates widespread implementation of impactful medical solutions across Singapore and China. The firm envisions a future where advanced technology ensures more accessible and efficient global healthcare.
Pureland Global Venture has 3 tracked investments across 3 companies. The latest tracked deal is $10.5M Series A in AMILI in June 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 16, 2022 | AMILI | $10.5M Series A | Tommy TEO | Blue7, Capital Code, Emtek Group, Enterprise Singapore, Pruksa Group, Seeds Capital, TVM Capital Healthcare |
| Jul 20, 2021 | Leo Cancer Care | $25.3M Series B | — | Alumni Ventures, CHC, Cosylab, Junson Capital, Radiation Business Solutions, Serra Ventures, Toret Devices, Warf Ventures, YU Galaxy |
| Jul 1, 2021 | Paradromics | $20.0M Seed | Prime Movers LAB | Harmonix Fund, Khosla Ventures, Satori Capital, Alpha Edison, Dolby Family Ventures, IT Farm, Synergy Ventures, Westcott Investment Group |
